CHAARTED: ADT + docetaxel for prostate cancer

(3:27)

CHAARTED Trial

(4:4)

Timing of ADT and Chemotherapy

(15:1econd)

New Concepts in ADT

(27:50)

CHAARTED Trial: A Game Changer

(5:38)

The CHAARTED Study—Treatment of CRPC with Docetaxel

(6:9)

CHAARTED TRIAL (Metastatic prostate cancer)

(1:25)

What every patient should know about ADT (hormone) therapy

(36:43)

Dr. Shore on Challenges with ADT in Recurrent Prostate Cancer

(1:5)

GST Audit by Officers (How to Handle) | Section 65 Audit | GST ADT-1 \u0026 GST ADT-2

(22:26)

What they don't tell you about Androgen Deprivation Therapy (ADT, hormone therapy)

(50:36)

Treating Lymph Node #ProstateCancer Metastases | #MarkScholzMD #AlexScholz #PCRI

(19:2)

PSA Less than 0.01 - Next Steps, Testosterone After Hormone Therapy | Answering YouTube Comments #58

(8:6)

Risks Of ADT in Recurrent Prostate Cancer

(39:50)

Radiotherapy with hormones for prostate cancer

(7:49)

Advancements in Prostate Cancer Treatment and Diagnosis

(1:43:56)

Androgen Deprivation Therapy (ADT) and Cognitive Health

(17:38)

What’s new in advanced and metastatic prostate cancer treatment | BCH Lecture Sept 23

(1:34:32)

Decipher in CHAARTED: Dr. Anis Hamid, MBBS

(7:14)

Intermittent Androgen Deprivation Therapy ADT in Prostate Cancer with Alicia Morgans, MD [EP 89]

(41:18)

Sieber on CHAARTED for Advanced Prostate Cancer

(1:36)

Assessing the ARANOTE Trial: Role of Darolutamide in Enhancing ADT for HSPC

(6:11)

Staying healthy when on ADT hormone therapy for prostate cancer

(3:29)

The Role of ADT in Prostate Cancer Recurrence

(29)

Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer

(3:7)

ADT as Foundational Therapy: Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

(40:9)

ADT as Treatment in Metastatic Prostate Cancer

(4:43)

Updates in ADT: Managing Adverse Effects

(13:9)

Dr. Sieber on the CHAARTED Trial

(1:36)